You are here

  • Home
  • Archive
  • Volume 107, Issue 6
  • Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry

Citation Tools

Article menu

Download PDFPDF

Clinical science
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hunt AR, Nguyen V, Arnold JJ, et al
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
British Journal of Ophthalmology 2023;107:842-848.